Open AccessMulti-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer
Author(s) -
Nuzhat Sial,
Saba Saeed,
Mukhtiar Ahmad,
Yasir Hameed,
Abdul Rehman,
Mohamed S. Abbas,
Asif Rizwan,
Hamad Ahmed,
Muzzamal Hussain,
Jalil Ur Rehman,
Muhammad Atif,
Muhammad Rashid Khan
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s327367
Subject(s) - human protein atlas , biomarker , survival analysis , medicine , cancer , in silico , biology , omics , bioinformatics , gene , computational biology , oncology , cancer research , genetics , protein expression
Cancer is one of the most common malignancies and the leading cause of death worldwide. As a member of the transmembrane emp24 domain (Tmed)/p24 family of proteins, TMED2 expression variations have been documented earlier in only a few subtypes of human cancers, and the multi-omics profiling of TMED2 as a shared biomarker in different other subtypes of human cancers remains to be uncovered.